Get the app!
Back to Trades
Grant4

VERTEX PHARMACEUTICALS INC / MA

VRTX

Total Value
$3.2M

Company Information

Ticker Symbol
VRTX
CIK
0000875320

Insider Information

Role
CEO & President, Director
DirectorOfficer
Location
BOSTON, MA

Filing Details

Filing Date
Feb 19, 2026
Transaction Date
Feb 17, 2026
Accession Number
0000875320-26-000090
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 17, 2026Common Stock16,326Grant/Award
Feb 17, 2026Common Stock6,554$483.75Tax Withholding$3.2M

Footnotes

  1. (F1)Restricted stock unit award that vests in installments beginning on February 20, 2027.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.